TANYA ALLMARAS: Open Payments
NPI 1427334929 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 52 payments from 20 companies in 2025. Trend: 2023 $620 · 2024 $1,043 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $240 |
| Novo Nordisk Inc | 6 | $110 |
| ABBVIE INC. | 4 | $92 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Exact Sciences Corporation | 2 | $50 |
| Amgen Inc. | 3 | $48 |
| Dexcom, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: ELIQUIS, NURTEC ODT, Wegovy, Symbravo, Cologuard Collection Kit, Dexcom G6 Transmitter, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across ID — which companies pay providers there.
